Utah Medical Products reported Q4 2024 revenue of $9.2M. Diluted EPS came in at $0.86.
Trailing eight quarters through Q4 2024
Common questions about Utah Medical Products's Q4 2024 earnings report.
Utah Medical Products (UTMD) reported Q4 2024 earnings on March 26, 2025.
Utah Medical Products reported revenue of $9.2M and diluted EPS of $0.86 for Q4 2024.
You can read the 10-K periodic report (0001096906-25-000308) directly on SEC EDGAR. The filing index links above go to sec.gov.